Court Rules to Reinstate Significant Restrictions on Abortion Medication but Not to Revoke FDA Approval of the Drug
Mifepristone will remain available under current regulations due to an earlier U.S. Supreme Court order.
08.16.23 (PRESS RELEASE) — Today, the U.S. Court of Appeals for the Fifth Circuit largely upheld an unprecedented order from Judge Matthew Kacsmaryk threatening access to mifepristone—one of two drugs used in medication abortion. The federal appellate court ruled for the second time to reinstate burdensome restrictions on mifepristone from pre-2016, but not to revoke FDA […]
North Carolina enacts a 12-week abortion ban, hearing on the medication abortion case, harms of abortion bans, and other top news on U.S. reproductive rights.
Lawsuit seeks to protect mifepristone access in Virginia, Montana, and Kansas in light of the drug’s legal uncertainty.
Health, Pharmaceutical and Legal Experts Urge Circuit Court to Reverse Order Attempting to Block FDA’s Approval of Abortion Drug
Case to be argued at the Fifth Circuit Court of Appeals on May 17.
The Center and Movement Partners Urge Court to Block Unprecedented Ruling Rejecting FDA’s Approval of Abortion Drug
Amicus brief of more than 100 reproductive rights, health, and justice partners highlights the proven safety and efficacy of the drug, the ruling’s “immediate and life-threatening consequences,” and the court’s reliance on “debunked data.”
Texas Court’s Radical Decision Attempts to Block FDA Approval of a Medication Abortion Drug Used for More Than 20 Years
Ruling is a devastating blow to abortion access across the U.S.
In an interview with MSNBC, President and CEO Nancy Northup discusses the lawsuit filed against the FDA to remove an abortion medication in all 50 states.
Anti-abortion advocates sue the FDA attempting to remove an abortion medication in all 50 states.